| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic diversity programmes for non-US international medical graduates
|
Villamar, Mauricio F
|
|
|
7 |
2 |
p. 115
|
artikel
|
| 2 |
Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models
|
DiMartini, Andrea F
|
|
|
7 |
2 |
p. 186-195
|
artikel
|
| 3 |
Correction to Lancet Gastroenterol Hepatol 2022; 7: 152–60
|
|
|
|
7 |
2 |
p. e2
|
artikel
|
| 4 |
Digging deeper into alcohol-related deaths
|
The Lancet Gastroenterology & Hepatology,
|
|
|
7 |
2 |
p. 107
|
artikel
|
| 5 |
Effect of prophylactic endoscopic clip placement on clinically significant post-endoscopic mucosal resection bleeding in the right colon: a single-centre, randomised controlled trial
|
Gupta, Sunil
|
|
|
7 |
2 |
p. 152-160
|
artikel
|
| 6 |
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
|
Lasa, Juan S
|
|
|
7 |
2 |
p. 161-170
|
artikel
|
| 7 |
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
|
Peyrin-Biroulet, Laurent
|
|
|
7 |
2 |
p. 128-140
|
artikel
|
| 8 |
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
|
Danese, Silvio
|
|
|
7 |
2 |
p. 118-127
|
artikel
|
| 9 |
Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunities
|
Ma, Christopher
|
|
|
7 |
2 |
p. 110-112
|
artikel
|
| 10 |
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
|
Haifer, Craig
|
|
|
7 |
2 |
p. 141-151
|
artikel
|
| 11 |
Modifying Rome IV for clinical practice
|
Burki, Talha Khan
|
|
|
7 |
2 |
p. 116
|
artikel
|
| 12 |
Oral lyophilised microbiota for the treatment of ulcerative colitis
|
Fischer, Monika
|
|
|
7 |
2 |
p. 108-109
|
artikel
|
| 13 |
Prevention of bleeding after EMR of colorectal lesions: when and how?
|
Mohapatra, Sonmoon
|
|
|
7 |
2 |
p. 109-110
|
artikel
|
| 14 |
Research in Brief
|
Baker, Holly
|
|
|
7 |
2 |
p. 117
|
artikel
|
| 15 |
Septic arthritis: a presentation of Crohn's disease
|
Özpolat, Hasan Tahsin
|
|
|
7 |
2 |
p. 196
|
artikel
|
| 16 |
The growth of faecal microbiota transplantation in the UK: time for a registry?
|
Inglis, David
|
|
|
7 |
2 |
p. 112-114
|
artikel
|
| 17 |
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
|
Papamichael, Konstantinos
|
|
|
7 |
2 |
p. 171-185
|
artikel
|
Tijdschrift beschrijving